Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bupivacaine Liposomes or Bupivacaine for Ultrasound-guided CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery
NCT06737341Phase 4Recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Oct 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Overall Opioid Consumption at 3 days. Started Oct 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06737341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06737341.